1. Cell Biology
  2. Developmental Biology
Download icon

Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway

  1. Barak Blum
  2. Adam N Roose
  3. Ornella Barrandon
  4. René Maehr
  5. Anthony C Arvanites
  6. Lance S Davidow
  7. Jeffrey C Davis
  8. Quinn P Peterson
  9. Lee L Rubin
  10. Douglas A Melton  Is a corresponding author
  1. Harvard Stem Cell Institute, Harvard University, United States
  2. University of Massachusetts Medical School, United States
Research Article
  • Cited 63
  • Views 6,532
  • Annotations
Cite this article as: eLife 2014;3:e02809 doi: 10.7554/eLife.02809

Abstract

Dysfunction or death of pancreatic β cells underlies both types of diabetes. This functional decline begins with β cell stress and de-differentiation. Current drugs for T2D lower blood glucose levels, but they do not directly alleviate β cell stress nor prevent, let alone reverse, β cell de-differentiation. We show here that Urocortin 3 (Ucn3), a marker for mature β cells, is down-regulated in the early stages of T2D in mice and when β cells are stressed in vitro. Using an insulin expression-coupled lineage tracer, with Ucn3 as a reporter for the mature β cell state, we screen for factors that reverse β cell de-differentiation. We find that a small molecule inhibitor of TGFβ receptor I (Alk5) protects cells from the loss of key β cell transcription factors and restores a mature β cell identity even after exposure to prolonged and severe diabetes.

Article and author information

Author details

  1. Barak Blum

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  2. Adam N Roose

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  3. Ornella Barrandon

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. René Maehr

    University of Massachusetts Medical School, Worcester, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Anthony C Arvanites

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Lance S Davidow

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. Jeffrey C Davis

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  8. Quinn P Peterson

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  9. Lee L Rubin

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  10. Douglas A Melton

    Harvard Stem Cell Institute, Harvard University, Cambridge, United States
    For correspondence
    dmelton@harvard.edu
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: Animal experiments were performed in compliance with the Harvard University International Animal Care and Use Committee (IACUC) guidelines (protocol #93-15).

Human subjects: Institutional review board approval for research use of human tissue was obtained from the Harvard University Faculty of Arts and Sciences. Human islets were obtained from NDRI (The National Disease Research Interchange). Donor anonymity was preserved, and the human tissue was collected under applicable regulations and guidelines regarding consent, protection of human subjects and donor confidentiality

Reviewing Editor

  1. Hideyuki Okano, Keio University School of Medicine, Japan

Publication history

  1. Received: March 16, 2014
  2. Accepted: September 15, 2014
  3. Accepted Manuscript published: September 16, 2014 (version 1)
  4. Version of Record published: October 22, 2014 (version 2)

Copyright

© 2014, Blum et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,532
    Page views
  • 778
    Downloads
  • 63
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Research organisms

Further reading

    1. Cancer Biology
    2. Cell Biology

    Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes

    Shima Ghoroghi et al.
    Research Article Updated

    Cancer extracellular vesicles (EVs) shuttle at distance and fertilize pre-metastatic niches facilitating subsequent seeding by tumor cells. However, the link between EV secretion mechanisms and their capacity to form pre-metastatic niches remains obscure. Using mouse models, we show that GTPases of the Ral family control, through the phospholipase D1, multi-vesicular bodies homeostasis and tune the biogenesis and secretion of pro-metastatic EVs. Importantly, EVs from RalA or RalB depleted cells have limited organotropic capacities in vivoand are less efficient in promoting metastasis. RalA and RalB reduce the EV levels of the adhesion molecule MCAM/CD146, which favors EV-mediated metastasis by allowing EVs targeting to the lungs. Finally, RalA, RalB, and MCAM/CD146, are factors of poor prognosis in breast cancer patients. Altogether, our study identifies RalGTPases as central molecules linking the mechanisms of EVs secretion and cargo loading to their capacity to disseminate and induce pre-metastatic niches in a CD146-dependent manner.

    1. Cell Biology

    Optogenetic control of PRC1 reveals its role in chromosome alignment on the spindle by overlap length-dependent forces

    Mihaela Jagrić et al.
    Research Article

    During metaphase, chromosome position at the spindle equator is regulated by the forces exerted by kinetochore microtubules and polar ejection forces. However, the role of forces arising from mechanical coupling of sister kinetochore fibers with bridging fibers in chromosome alignment is unknown. Here we develop an optogenetic approach for acute removal of PRC1 to partially disassemble bridging fibers and show that they promote chromosome alignment. Tracking of the plus-end protein EB3 revealed longer antiparallel overlaps of bridging microtubules upon PRC1 removal, which was accompanied by misaligned and lagging kinetochores. Kif4A/kinesin-4 and Kif18A/kinesin-8 were found within the bridging fiber and largely lost upon PRC1 removal, suggesting that these proteins regulate the overlap length of bridging microtubules. We propose that PRC1-mediated crosslinking of bridging microtubules and recruitment of kinesins to the bridging fiber promotes chromosome alignment by overlap length-dependent forces transmitted to the associated kinetochore fibers.

    1. Cell Biology

    Cross-compartment signal propagation in the mitotic exit network

    Xiaoxue Zhou et al.
    Research Article

    In budding yeast, the mitotic exit network (MEN), a GTPase signaling cascade, integrates spatial and temporal cues to promote exit from mitosis. This signal integration requires transmission of a signal generated on the cytoplasmic face of spindle pole bodies (SPBs; yeast equivalent of centrosomes) to the nucleolus, where the MEN effector protein Cdc14 resides. Here, we show that the MEN activating signal at SPBs is relayed to Cdc14 in the nucleolus through the dynamic localization of its terminal kinase complex Dbf2-Mob1. Cdc15, the protein kinase that activates Dbf2-Mob1 at SPBs, also regulates its nuclear access. Once in the nucleus, priming phosphorylation of Cfi1/Net1, the nucleolar anchor of Cdc14, by the Polo-like kinase Cdc5 targets Dbf2-Mob1 to the nucleolus. Nucleolar Dbf2-Mob1 then phosphorylates Cfi1/Net1 and Cdc14, activating Cdc14. The kinase-primed transmission of the MEN signal from the cytoplasm to the nucleolus exemplifies how signaling cascades can bridge distant inputs and responses.